180 Life Sciences Corp (ATNF)

NASDAQ
2.66
+0.13(+5.14%)
After Hours
2.81
+0.15(+5.64%)
- Real-time Data
  • Volume:
    496,794
  • Bid/Ask:
    2.60/2.81
  • Day's Range:
    2.65 - 2.96

ATNF Overview

Prev. Close
2.53
Day's Range
2.65-2.96
Revenue
-
Open
2.65
52 wk Range
2.25-12.98
EPS
-0.95
Volume
496,794
Market Cap
90.48M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
980,478
P/E Ratio
-
Beta
-0.22
1-Year Change
-28.88%
Shares Outstanding
34,016,456
Next Earnings Date
01 Mar 2022
What is your sentiment on 180 Life Sciences Corp?
or
Market is currently closed. Voting is open during market hours.

180 Life Sciences Corp Company Profile

Employees
0

180 Life Sciences Corp. is a clinical stage biotechnology company. The Company is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and inflammatory diseases. The Company has three product development platforms each of which focused on different diseases, pains or medical conditions and target different factors, molecules or proteins, and has their own product candidates, including Anti-TNF, which focusing on fibrosis and anti-tumour necrosis factor (anti-TNF); SCAs focused on drugs, which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs); and α7nAChR focusing on alpha 7 nicotinic acetylcholine receptor (α7nAChR). It conducting clinical trials only for certain indications under the anti-TNF platform. Out of its three product development platforms, only the SCAs platform, involves products that are related to CBD.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsStrong SellStrong SellSellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.